Nephrology Doctors in Hannibal, MO - Medicare Status, Address, Contact

2 Nephrology doctors found. Showing 1 - 2

Dr. Karol Edward Rosner, M.D.
Internal Medicine - Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 6500 Hospital Dr, Hannibal, MO 63401
Phone: 573-629-3500 Fax: 573-629-3515

Caitlin Amanda Petry, MSN, FNP-C
Internal Medicine - Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 6500 Hospital Dr, Hannibal, MO 63401
Phone: 573-629-3400 Fax: 573-629-3314

News Archive

Malawi government addressing drug, medical supply shortages in wake of aid withdrawals

As international donors "remain reluctant to release aid meant for the health sector" in Malawi "amid allegations of pilfering and corruption in the procurement of drugs," "patients seeking medical treatment at government-run medical facilities are unable to access medication such as antiretrovirals (ARVs), anti-malarial drugs and even painkillers," Inter Press Service reports, adding, "Health facilities are also experiencing a shortage of medical equipment such as gloves, and malaria and HIV/AIDS testing kits."

MMRC initiates Phase Ib/II study of Treanda in combination with Revlimid and dexamethasone

The Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a Phase Ib/II study of bendamustine (Treanda®), an anticancer agent currently approved for the treatment of chronic lymphocytic leukemia (CLL) and B-cell non-Hodgkin's lymphoma (NHL), in combination with lenalidomide (Revlimid®) and dexamethasone in patients with relapsed multiple myeloma. The trial, led by Shaji Kumar, MD, of Mayo Clinic, is open for enrollment at Mayo Clinic (Rochester, Minn.), City of Hope Cancer Center (Duarte, Calif.) and the University of Chicago (Chicago, Ill).

Mechanism behind nicotine dependency revealed

The research is being published the week of October 1, 2007, in an advance, online issue of the journal Proceedings of the National Academy of Sciences (PNAS).

FDA approves Iroko Pharmaceuticals' ZORVOLEX capsules

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved ZORVOLEX™ (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the treatment of mild to moderate acute pain in adults. ZORVOLEX was approved at dosage strengths that are 20 percent lower than currently available diclofenac products.

Food insecurity has increased significantly among older US adults, shows study

From 2007 to 2016, food insecurity-or limited access to nutritious foods because of a lack of financial resources-increased significantly from 5.5% to 12.4% among older US adults, and the increase was more pronounced among individuals with lower income.

Nephrology Doctors in Hannibal, MO Accepting Medicare